title: Schedules of Controlled Substances: Removal of [123I]Ioflupane From Schedule II of the Controlled Substances Act. Final rule.
abstract: With the issuance of this final rule, the Administrator of the Drug Enforcement Administration removes [123I]ioflupane from the schedules of the Controlled Substances Act. This action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after an opportunity for a hearing through formal rulemaking. Prior to the effective date of this rule, [123I]ioflupane was, by definition, a schedule II controlled substance because it is derived from cocaine via ecgonine, both of which are schedule II controlled substances. This action removes the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle [123I]ioflupane.
mesh_terms: D003042:Cocaine / Q000031:analogs & derivatives; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D007457:Iodine Radioisotopes; D007880:Legislation, Drug; D009662:Nortropanes / Q000145:classification*; D014481:United States
chemical_list: D007457:Iodine Radioisotopes; D009662:Nortropanes; D003042:Cocaine